Mũ thị trường của China Resources Jiangzhong Pharmaceutical Co.,Ltd là gì (600750)

Giới hạn thị trường của China Resources Jiangzhong Pharmaceutical Co.,Ltd (600750) là $2.21B

Doanh thu China Resources Jiangzhong Pharmaceutical Co.,Ltd (600750)

Q: Giá của China Resources Jiangzhong Pharmaceutical Co.,Ltd là bao nhiêu (600750)

Giá của China Resources Jiangzhong Pharmaceutical Co.,Ltd (600750) là $3.48

China Resources Jiangzhong Pharmaceutical Co.,Ltd functions as a prominent Chinese manufacturer of a wide array of pharmaceutical products for the domestic market. Its extensive product portfolio includes a variety of over-the-counter (OTC) medications, such as tablets designed for stomach-strengthening and digestion promotion, lactobacillus tablets, and triple live bifidobacterium enteric-coated capsules. Other significant OTC offerings feature compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, Fritillaria and loquat capsules, bezoar and snake gallbladder Fritillaria liquid, and compound gold melon seed. Beyond pharmaceutical drugs, the company also provides health consumer goods. These range from general nourishing products and rehabilitation nutrition items to specialized solutions for gastrointestinal and liver health. Furthermore, China Resources Jiangzhong Pharmaceutical manufactures prescription drugs. This segment encompasses a broad selection of Traditional Chinese Medicine (TCM) products, including Shenbao capsules, Paishi granules, Huangba Shengmai drink, Bazhen Yimu capsules, Zhenju Jiangya tablets, Shuangju granules, Zhikang tablets, and Shuxiong granules. It also produces chemical medications such as lumbrokinase enteric-coated capsules, Rabelagat sodium enteric-coated tablets, and chloroprocaine hydrochloride. Additionally, the company processes and supplies essential medicinal raw materials, including stir-fried Chinese jujube seeds, French pinellia, and vinegar-soaked northern bupleurum. The company, headquartered in Nanchang, China, was established in 1996. It was formerly identified as Jiang Zhong Pharmaceutical Co.,Ltd before officially adopting its current name, China Resources Jiangzhong Pharmaceutical Co.,Ltd, in January 2025.

Năm	Doanh thu	Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.

Năm

Doanh thu

Thay đổi

Không đủ dữ liệu cho ngày được cung cấp.

Công ty	Doanh thu	Chênh lệch doanh thu	Quốc gia
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Công ty

Doanh thu

Chênh lệch doanh thu

Quốc gia